IP Library Granted Patent US 11,662,290
Granted Patent B2
US 11,662,290 · App. 16/466,364 · Granted May 30, 2023

Flexibility measurements of injectable gels

Inventors: Morgan Karlsson (Knivsta, SE); Åke Öhrlund (Uppsala, SE)
Assignee: Galderma Holding SA
G01N11/165A61L27/20A61L27/52A61L27/58G01N11/142G01N11/16G01N11/162A61K31/728A61L27/50A61L2400/06A61L2430/34G01N2011/0026G06F9/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,662,290
App. No.
16/466,364
Granted
May 30, 2023
Kind
B2
Abstract

A process for evaluating rheological characteristics of an injectable gel including measuring the flexibility, wherein the flexibility is evaluated by measuring the strain at the crossover point of the amplitude sweep. The process may include subjecting an injectable gel to oscillating mechanical stresses to determine G′ and G″ as a function of strain (γ) in an amplitude sweep, determining the crossover point as the point at which G′ and G″ have the same value, determining the strain γ cross at the crossover point, and determining the flexibility of the injectable gel as γ cross or proportional to γ cross . Further, a method of comparison of dermal fillers by measuring their flexibility and a method of evaluation of dermal filler behavior in human skin by measuring the flexibility.

Claims (20)

1. A process for evaluating flexibility of an injectable gel, the process comprising:

subjecting the injectable gel to oscillating mechanical stresses to determine elastic modulus (G′) and viscous modulus (G″) of the injectable gel as a function of strain (γ) in an amplitude sweep of the injectable gel;

determining the strain (γ cross ) at a crossover point of the amplitude sweep of the injectable gel, wherein the crossover point of the amplitude sweep is where G′ and G″ have the same value;

determining the flexibility of the injectable gel as the strain γ cross at the crossover point; and

comparing the flexibility of the injectable gel with a flexibility value of a reference gel, wherein flexibility of the injectable gel higher than the flexibility value of the reference gel indicates that the injectable gel is more suitable than the reference gel for being implanted at facial regions that are subjected to movement.

2. The process according to claim 1 , wherein the amplitude sweep is performed by increasing deformation of the injectable gel until a change in both G′ and G″ are observed.

3. The process according to claim 1 , wherein determining the strain (γ cross ) at the crossover point of the amplitude sweep of the injectable gel is performed by plotting G′ and G″ as a function of the strain (γ) and selecting the crossover point as the point where the plot of G′ and the plot of G″ intersect.

4. The process according to claim 3 , wherein plotting G′ and G″ as a function of the strain (γ) comprises performing a frequency sweep at a fixed strain before performing the amplitude sweep.

5. The process according to claim 1 , wherein the flexibility of the injectable gel is measured in percentage (%).

6. The process according to claim 1 , wherein the amplitude sweep is performed at a frequency of between 0.5 Hz-1.5 Hz.

7. The process according to claim 1 , wherein the injectable gel is a dermal filler comprising crosslinked hyaluronic acid.

8. A method of comparing suitability of injectable gels as dermal fillers, the method comprising:

evaluating the flexibility of a plurality of injectable gels that are candidate dermal fillers according to the method of claim 1 ;

comparing the evaluated flexibility between or among the plurality of injectable gels; and

selecting a dermal filler from the plurality of injectable gels as a dermal filler suitable for injection based on the comparison.

9. The method according to claim 8 , wherein the injectable gel having the highest flexibility value of the plurality of injectable gels is selected as the dermal filler suitable for injection in the facial area.

10. The process according to claim 1 , wherein determining the strain (γ cross ) at the crossover point of the amplitude sweep of the injectable gel, wherein the crossover point of the amplitude sweep is where G′ and G″ have the same value, comprises

receiving input data of G′ and G″ as a function of the strain γ of the injectable gel.

11. The process according to claim 10 , further comprising displaying the flexibility of the injectable gel on a computer screen.

12. The process of claim 10 , wherein the process is performed using a device in communication with computer-executable components run on a processing unit included within the device.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 27, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 061113/0710 →
CHANGE OF NAME Recorded Dec 31, 2020
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 054899/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: KARLSSON, MORGAN; ÖHRLUND, ÅKE
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 052805/0137 →
Continuity (2)
Provisional Application 62431093 · Dec 7, 2016
Related Publication 20200072721A1 · Mar 5, 2020